Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Tutt

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Trends in Molecular Medicine|December 10, 2002
The relationship between the roles of BRCA genes in DNA repair and cancer predispositionAndrew Tutt, Alan Ashworth
European Journal of Cancer (Oxford, England : 1990)|November 26, 2008
Can genetic testing guide treatment in breast cancer?Andrew Tutt, Alan Ashworth
The Lancet. Oncology|October 14, 2003
Close relatives or distant cousins?Andrew Tutt, Alan Ashworth
Breast (Edinburgh, Scotland)|October 22, 2011
PARP inhibitors--current status and the walk towards early breast cancerJennifer Glendenning, Andrew Tutt
Therapeutic Advances in Medical Oncology|November 9, 2019
Controversial issues in the neoadjuvant treatment of triple-negative breast cancerAmanda Fitzpatrick, Andrew Tutt
Current Opinion in Oncology|October 12, 2011
Molecular heterogeneity of triple-negative breast cancer and its clinical implicationsSheeba Irshad, Paul Ellis, Andrew Tutt
Nature Reviews. Cancer|October 29, 2004
Hallmarks of 'BRCAness' in sporadic cancersNicholas Turner, Andrew Tutt, Alan Ashworth
Expert Review of Anticancer Therapy|September 16, 2011
Therapeutic potential of PARP inhibitors for metastatic breast cancerSheeba Irshad, Alan Ashworth, Andrew Tutt
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2016
Tandem duplications contribute to not one but two distinct phenotypesJohnathan Watkins, Andrew Tutt, Anita Grigoriadis
Current Opinion in Pharmacology|June 16, 2005
Targeting the DNA repair defect of BRCA tumoursNicholas Turner, Andrew Tutt, Alan Ashworth
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Trends in Molecular Medicine|December 10, 2002
The relationship between the roles of BRCA genes in DNA repair and cancer predispositionAndrew Tutt, Alan Ashworth
European Journal of Cancer (Oxford, England : 1990)|November 26, 2008
Can genetic testing guide treatment in breast cancer?Andrew Tutt, Alan Ashworth
The Lancet. Oncology|October 14, 2003
Close relatives or distant cousins?Andrew Tutt, Alan Ashworth
Breast (Edinburgh, Scotland)|October 22, 2011
PARP inhibitors--current status and the walk towards early breast cancerJennifer Glendenning, Andrew Tutt
Therapeutic Advances in Medical Oncology|November 9, 2019
Controversial issues in the neoadjuvant treatment of triple-negative breast cancerAmanda Fitzpatrick, Andrew Tutt
Current Opinion in Oncology|October 12, 2011
Molecular heterogeneity of triple-negative breast cancer and its clinical implicationsSheeba Irshad, Paul Ellis, Andrew Tutt
Nature Reviews. Cancer|October 29, 2004
Hallmarks of 'BRCAness' in sporadic cancersNicholas Turner, Andrew Tutt, Alan Ashworth
Expert Review of Anticancer Therapy|September 16, 2011
Therapeutic potential of PARP inhibitors for metastatic breast cancerSheeba Irshad, Alan Ashworth, Andrew Tutt
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2016
Tandem duplications contribute to not one but two distinct phenotypesJohnathan Watkins, Andrew Tutt, Anita Grigoriadis
Current Opinion in Pharmacology|June 16, 2005
Targeting the DNA repair defect of BRCA tumoursNicholas Turner, Andrew Tutt, Alan Ashworth
Pageof 10